Supplements That Help With Hair Loss on Zepbound (Tirzepatide): Evidence-Based Options

What the Zepbound studies actually show

The August 2026 Zepbound prescribing information reports hair loss in pooled weight-reduction Studies 1 and 2. Rates were 5% with 5 mg, 4% with 10 mg and 5% with 15 mg, versus 1% with placebo. These pooled, rounded label figures should not be described as one study's exact dose-specific result. The label associates reported hair loss with weight reduction; it does not establish a supplement treatment. [1]

The report does not prove that every person with shedding has telogen effluvium, that nutritional deficiency is always present, or that a direct medication contribution has been excluded. The pattern of shedding, diet, weight change and other possible causes all matter.

The American Academy of Dermatology describes telogen effluvium as excessive shedding that can follow substantial weight loss or another stressor. It often becomes noticeable months after the event. Temporary shedding and female or male pattern hair loss are different problems, and can require different approaches. [2]

What a supplement can reasonably do

There are two separate questions:

1. Is there a deficiency or an intake problem that needs correction?
2. Does a particular supplement regrow hair in people taking Zepbound?

The first may have an actionable answer. The second needs direct evidence and cannot be answered by transferring every result from bariatric surgery, alopecia areata or another hair-loss condition to tirzepatide treatment.

A review of vitamins and minerals in hair loss found conflicting evidence and called for better controlled studies. Nutrition can be relevant without proving that everyone who sheds needs the same doses, blood targets or combined hair supplement. [3]

Iron and ferritin: correct deficiency, avoid a universal hair target

Ferritin helps assess iron stores, but inflammation can affect the result. NIH describes iron assessment using the clinical situation, dietary intake and laboratory findings rather than one isolated number. A normal hemoglobin result also does not answer every iron-status question. [4]

A systematic review of 36 studies, involving 10,029 participants, found lower ferritin values among women with nonscarring alopecia. That is an association across several kinds of hair loss. It does not establish that supplementing every Zepbound patient until ferritin exceeds 70 ng/mL will restore hair. [5]

If iron deficiency is established, its cause and treatment belong in the plan. The amount, formulation and follow-up depend on the situation. An absorption study in iron-deficient anemic women cannot be turned into a guaranteed hair-regrowth protocol for everyone receiving tirzepatide.

Zinc: more is not automatically better

Zinc deficiency can be relevant to hair changes, but the available hair-loss evidence does not establish a standard 25-50 mg daily treatment for all Zepbound users. A study of people with alopecia areata is not a trial of weight-loss-associated shedding. [3]

NIH gives an adult tolerable upper intake level of 40 mg/day and describes copper-absorption problems with 50 mg or more used over weeks. That does not mean a medically supervised deficiency treatment can never exceed the limit. It does mean the dose should not become the default ingredient in a hair-growth stack, with another supplement automatically added to compensate. [6]

Read the amount of elemental zinc on the label and account for other supplements already being used. Treatment aimed at correcting a deficiency has a different purpose from adding zinc when intake and status are adequate.

Vitamin D: testing and treatment depend on the indication

The Endocrine Society's 2024 prevention guideline does not set a 30-50 ng/mL target for hair regrowth. It advises against routine vitamin D screening in generally healthy adults with obesity who lack an established testing indication, and notes that outcome-specific blood thresholds have not been established in that population. [7]

This is not a guideline for treating an already diagnosed deficiency or another specific condition. It also does not support a blanket high-dose loading regimen for hair shedding on Zepbound. The useful question is whether there is an indication to test or treat, rather than whether everyone should reach one number.

Biotin: the evidence is narrower than the marketing

A 2017 review found 18 reported cases of improvement involving hair or nails. All had an underlying disorder affecting hair or nail growth; they were not all proven cases of biotin deficiency. The authors found insufficient evidence for routine supplementation in healthy individuals. [8]

NIH lists an adult adequate intake of 30 micrograms daily. That nutritional value is not evidence that milligram doses prevent Zepbound-related shedding. NIH also describes interference with some laboratory assays. Tell the testing team what supplement and amount you take rather than assuming a standard dose or brief pause fits every assay. [9]

Protein and food intake: assess what is missing

Appetite changes can make it harder to maintain a varied diet. Reviewing the actual meals is more useful than adding a large supplement list without knowing what is missing.

The 2025 joint advisory on nutrition during GLP-1 treatment discusses nutrient adequacy, protein and preservation of muscle and bone. It is an expert advisory informed by research and clinical experience, not a randomized trial proving one protein target prevents hair loss. [10]

Start by identifying practical sources you can tolerate, such as eggs, dairy, beans, fish, poultry or a suitable protein drink. A drink can help meet an intake goal when meals are difficult; it has not been established as a stand-alone treatment for tirzepatide-associated shedding. The appropriate amount depends on the overall diet and individual needs rather than a fixed calculation presented as a universal hair prescription.

Collagen, omega-3 and other hair products

Evidence from a combination product cannot tell you which ingredient produced a result. A study in a different hair-loss population also does not establish prevention or treatment of shedding during Zepbound use. That applies to omega-3 blends, collagen and multi-ingredient hair gummies. [3]

Before comparing products, ask what the study actually tested: the exact formula, the type of hair loss, the comparison group and the outcome measured. An improvement in one study is not a guarantee of regrowth in a different setting.

Minoxidil is a medicine, not a nutritional supplement. Evidence for pattern hair loss does not automatically validate an exact six-month treatment rule for Zepbound-related shedding. The diagnosis should determine whether it is relevant.

A useful evaluation and follow-up plan

Record when shedding began, the timing and pace of weight change, typical food intake, medicines and supplements, and whether the loss is diffuse or follows a pattern. These details help distinguish nutritional problems from other explanations.

A clinician can select tests based on that assessment. There is no label-established requirement for every Zepbound patient to have CBC, ferritin, zinc, vitamin D, thyroid and biotin tests on a fixed baseline, three-month and six-month schedule. A test that is useful for one suspected problem need not become a routine panel for everyone.

If a deficiency is found, follow its treatment and reassessment plan. Track both the nutritional response and the course of shedding. Correcting a laboratory value and observing hair regrowth are different outcomes, and the timing can differ.

What to expect from recovery

For stress-related telogen effluvium, the AAD explains that fullness can return over six to nine months as the body readjusts. An ongoing stressor can prolong shedding. That is general information about the condition, not a guaranteed Zepbound-specific timeline. [2]

Persistent shedding can have more than one cause. It should not be treated by repeatedly raising supplement doses until a promised date for regrowth arrives. A review of the diagnosis, nutritional intake and treatment plan provides a more useful next step.